Vol 10, No 3 (June 06, 2021): Chinese Clinical Oncology

Editorial

Drug development in the era of precision medicine in oncology—Clues beyond randomization

Pauline du Rusquec, Thomas Filleron, Christophe Le Tourneau

PDF Pages: 23 Full Text (2108) COI Form Open Access

Original Article

Anaesthesia for radiotherapy in paediatric oncology—a retrospective observational study in an Asian population

Lydia W. Li, Gail WY Chua, Koh Wenjun, Choon Looi Bong

PDF Pages: 24 Full Text (3038) Reporting Checklist Data Sharing Statement COI Form Open Access

Epidemiology of gallbladder cancer in the Unites States: a population-based study

Motasem Alkhayyat, Mohannad Abou Saleh, Thabet Qapaja, Mohammad Abureesh, Ashraf Almomani, Emad Mansoor, Prabhleen Chahal

PDF Pages: 25 Full Text (3386) Reporting Checklist Data Sharing Statement COI Form Open Access

High risk of recurrence for grade II meningioma: a 10-year multicenter analysis of prognosis factors

Laura Bender, François Somme, Benoît Lhermitte, Guido Ahle, Mathieu Boone, Marie Blonski, Celso Pouget, Gilles Truc, Hélène Cebula, Georges Noël

PDF Pages: 26 Full Text (16407) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

The applicability of the ACOSOG Z0011 Criteria to breast cancer patients in Hong Kong

Vivian Man, Man Shan Lo, Ava Kwong

PDF Pages: 27 Full Text (5018) Reporting Checklist Data Sharing Statement COI Form Open Access

Characteristics of Asian 4 countries on cancer clinical trials registered in the International Clinical Trials Registry Platform between 2005 and 2018

Mariko Doi, Keiko Yukawa, Hajime Sato

PDF Pages: 28 Full Text (1787) COI Form Open Access

Case Report

A case of pseudomyxoma peritonei successfully treated with trifluridine/tipiracil (TAS-102) and bevacizumab after palliative debulking surgery

Satoshi Hirano, Yoshimasa Gohda, Hideki Miyazaki, Nami Hayama, Shinichiro Shimizu, Toru Igari, Hideaki Yano

PDF Pages: 29 Full Text (3768) Reporting Checklist Peer Review File COI Form Open Access

Editorial Commentary

The role of ramucirumab and pembrolizumab combination in patients with advanced non-small cell lung cancer, gastroesophageal adenocarcinoma, or urothelial carcinoma

Jane E. Rogers, Jaffer A. Ajani

PDF Pages: 30 Full Text (1964) COI Form Open Access

The prognostic nomogram in platinum-resistant ovarian cancer: how to develop and validate?

Kuo-Chang Wen, Pi-Lin Sung, Hung-Cheng Lai

PDF Pages: 31 Full Text (2300) COI Form Open Access

Why should localized gastric adenocarcinoma patients fare poorly after adjunctive therapy compared to surgery alone?

Jane E. Rogers, Allison Trail, Jaffer A. Ajani

PDF Pages: 32 Full Text (1123) COI Form Open Access

Letter to the Editor

Ramucirumab and other new systemic therapies for hepatocellular carcinoma: still uncovered the problem of Child-Pugh B patients

Markus Wilhelmi

PDF Pages: 33 Full Text (1109) COI Form Open Access